IRLAB THERAPEUTICS AB SER. A revenue for the last year amounted to 5.70 M SEK, the most of which — 5.68 M SEK — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 61.14 M SEK. The greatest contribution to the revenue figure was made by United States — last year it brought IRLAB THERAPEUTICS AB SER. A 4.22 M SEK.